Search

Your search keyword '"CENTRAL nervous system viral diseases"' showing total 2,910 results

Search Constraints

Start Over You searched for: Descriptor "CENTRAL nervous system viral diseases" Remove constraint Descriptor: "CENTRAL nervous system viral diseases"
2,910 results on '"CENTRAL nervous system viral diseases"'

Search Results

1. Long-term Elevation of Complement Factors in Cerebrospinal Fluid of Patients With Borna Disease Virus 1 Encephalitis.

2. Targeted whole-viral genome sequencing from formalin-fixed paraffin-embedded neuropathology specimens.

4. Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A CIBMTR analysis.

5. Epidemiological and clinical overview of the 2024 Oropouche virus disease outbreaks, an emerging/re‐emerging neurotropic arboviral disease and global public health threat.

6. The Role of Peripheral Inflammatory Markers and Coagulation Factors in Patients with Central Nervous System (CNS) Immune Disease and Glioma.

7. Neonatal varicella.

8. Microglia as potential key regulators in viral-induced neuroinflammation.

9. Editorial: Trends in neuroimmunology: cross-talk between brain-resident and peripheral immune cells in both health and diseasea.

10. Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT).

11. Language impairments in seropositive and seronegative autoimmune encephalitis.

12. Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers?

13. Exploring the role of brain-derived extracellular vesicles in viral infections: from pathological insights to biomarker potential.

14. Cystatin F attenuates neuroinflammation and demyelination following murine coronavirus infection of the central nervous system.

15. The role of annexins in central nervous system development and disease.

16. Development Perspectives for Curative Technologies in Primary Demyelinating Disorders of the Central Nervous System with Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) at the Forefront

17. The level of cytokines in tears as a novel indicator of demyelinating diseases.

19. CNS involvement in myotonic dystrophy type 1: does sex play a role?

20. Gas6/TAM system as potential biomarker for multiple sclerosis prognosis.

21. The Role of Neutrophils in Multiple Sclerosis and Ischemic Stroke.

22. The Effects of Neuroactive Steroids on Myelin in Health and Disease.

23. SARS-CoV-2-related myelitis: two cases from a major neurological clinic in Central Italy.

24. Clinical and therapeutic challenges of smouldering multiple sclerosis.

25. Choroid plexus imaging in multiple sclerosis management -- a systematic review.

26. Ameliorative effects of acetyl-L-carnitine on corpus callosum and functional recovery in demyelinated mouse model.

27. Challenges in Diagnosis and Therapeutic Strategies in Late-Onset Multiple Sclerosis.

28. Clinical and radiological spectrum of acquired inflammatory demyelinating diseases of the central nervous system in a tertiary care center.

29. Psychotropic prescribing in psychiatric disorders in neurological diseases: stroke, traumatic brain injury, multiple sclerosis, and epilepsy.

30. Reduced tear fluid production in neurological diseases: a cohort study in 708 patients.

31. Micro‐diffusely abnormal white matter: An early multiple sclerosis lesion phase with intensified myelin blistering.

32. Lymphocytic Choriomeningitis Virus (LCMV): Current Status and Future Directions for Clinical and Molecular Diagnostic Techniques.

33. Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review.

34. Brain-Derived Neurotrophic Factor in Multiple Sclerosis Disability: A Prospective Study.

35. Sepsis-associated encephalopathy: Autophagy and miRNAs regulate microglial activation.

36. Anti-N-methyl-D-aspartate receptor type autoimmune encephalitis with severe pneumonia: a case report.

37. Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis—A Real-World Scenario.

38. Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as predictors of MS severity: a retrospective cohort study.

39. COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.

40. Metagenomic next-generation sequencing for diagnosis of infectious encephalitis and meningitis: a retrospective study of 90 patients.

41. Animal Models of Enterovirus D68 Infection and Disease

42. Editorial: CNS myeloid cell function in health and disease.

44. Monkeypox virus-associated meningoencephalitis diagnosed by detection of intrathecal antibody production.

45. Understanding the Neurotrophic Virus Mechanisms and Their Potential Effect on Systemic Lupus Erythematosus Development.

47. Profiling and Benchmarking Central Nervous System Infections in an Infectious Diseases Intensive Care Unit.

48. Encefalitis aguda diseminada en paciente pediátrico: reporte de caso.

50. Oxidative Stress, Serum Mineral and Trace Element Levels in Patients with Multiple Sclerosis with or without Restless Legs Syndrome.

Catalog

Books, media, physical & digital resources